[go: up one dir, main page]

IL129662A0 - Composition for the treatment of asthma containing loratadine and a decongestant - Google Patents

Composition for the treatment of asthma containing loratadine and a decongestant

Info

Publication number
IL129662A0
IL129662A0 IL12966297A IL12966297A IL129662A0 IL 129662 A0 IL129662 A0 IL 129662A0 IL 12966297 A IL12966297 A IL 12966297A IL 12966297 A IL12966297 A IL 12966297A IL 129662 A0 IL129662 A0 IL 129662A0
Authority
IL
Israel
Prior art keywords
decongestant
treatment
composition
containing loratadine
asthma containing
Prior art date
Application number
IL12966297A
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of IL129662A0 publication Critical patent/IL129662A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL12966297A 1996-10-31 1997-10-29 Composition for the treatment of asthma containing loratadine and a decongestant IL129662A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73966996A 1996-10-31 1996-10-31
PCT/US1997/019158 WO1998018470A1 (en) 1996-10-31 1997-10-29 Composition, for the treatment of asthma, containing loratadine and a decongestant

Publications (1)

Publication Number Publication Date
IL129662A0 true IL129662A0 (en) 2000-02-29

Family

ID=24973307

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12966297A IL129662A0 (en) 1996-10-31 1997-10-29 Composition for the treatment of asthma containing loratadine and a decongestant

Country Status (21)

Country Link
EP (1) EP0941091A1 (en)
JP (1) JP2000505104A (en)
KR (1) KR20000052922A (en)
CN (1) CN1235545A (en)
AR (1) AR008908A1 (en)
AU (1) AU731756B2 (en)
BR (1) BR9712705A (en)
CA (1) CA2268546A1 (en)
CO (1) CO4910128A1 (en)
CZ (1) CZ150999A3 (en)
HU (1) HUP9904075A3 (en)
ID (1) ID23431A (en)
IL (1) IL129662A0 (en)
NO (1) NO992062D0 (en)
NZ (1) NZ335078A (en)
PE (1) PE11399A1 (en)
PL (1) PL333056A1 (en)
SK (1) SK54599A3 (en)
TR (1) TR199901003T2 (en)
WO (1) WO1998018470A1 (en)
ZA (1) ZA979731B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999021556A1 (en) * 1997-10-29 1999-05-06 J-Med Pharmaceuticals, Inc. Antihistamine/decongestant regimens for treating rhinitis
US6132758A (en) 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
IT1303671B1 (en) * 1998-07-28 2001-02-23 Nicox Sa SALTS OF NITRIC ACID WITH ACTIVE DRUGS IN THE TREATMENT OF DISEASES OF THE RESPIRATORY SYSTEM
PA8481801A1 (en) * 1998-09-10 2000-09-29 Schering Corp METHODS AND COMPOSITIONS FOR TREATING SINUSITIS, OTITIS MEDIA AND OTHER RELATED DISORDERS USING ANTIHISTAMINES
US6521254B2 (en) 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
KR100505899B1 (en) * 1999-02-23 2005-08-01 주식회사유한양행 Pharmaceutical capsule compositions containing loratadine and pseudoephedrine
ATE253354T1 (en) * 1999-02-23 2003-11-15 Yuhan Corp CAPSULES WITH COMPOSITIONS CONTAINING LORATADINE AND PSEUDOEPHEDRINE
AU3924500A (en) * 1999-03-29 2000-10-16 Schering Corporation Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine
WO2001045668A2 (en) * 1999-12-20 2001-06-28 Schering Corporation Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
SK287105B6 (en) * 1999-12-20 2009-12-07 Schering Corporation Bilayer sustained release oral dosage composition
JP5592042B2 (en) * 2000-04-14 2014-09-17 ジェイ−メド ファーマシューティカルズ，インコーポレーティッド Single dose antihistamine / decongestant formulation for the treatment of rhinitis
BR0111018A (en) * 2000-05-25 2004-02-17 Schering Corp Liquid and solid stable formulations
MXPA03011705A (en) * 2001-06-20 2004-03-19 Schering Corp Antihistamines for the treatment of nasal congestion and nasal obstruction.
RU2423979C2 (en) * 2005-06-17 2011-07-20 АФТ Фармасьютикалз Лимитед Novel pharmaceutic composition and its application in method of treatment of patients with hyperaemia and edema of mucous membrane of upper airways
NZ575838A (en) 2005-06-17 2010-10-29 Aft Pharmaceuticals Ltd Composition comprising loratadine and phenylephrine and its use in a method for treatment of patients with upper respiratory mucosal congestion
CN104161736A (en) * 2006-06-01 2014-11-26 Msd消费保健品公司 Sustained release pharmaceutical dosage form containing phenylephrine
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
KR101540191B1 (en) * 2014-02-24 2015-07-28 성균관대학교산학협력단 Composition comprising Loratadine for anti-inflammation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1110397A (en) * 1964-10-02 1968-04-18 Mead Johnson & Co Ephedrine composition
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine

Also Published As

Publication number Publication date
NO992062L (en) 1999-04-29
PL333056A1 (en) 1999-11-08
JP2000505104A (en) 2000-04-25
EP0941091A1 (en) 1999-09-15
BR9712705A (en) 1999-10-26
SK54599A3 (en) 2000-08-14
CZ150999A3 (en) 1999-10-13
TR199901003T2 (en) 1999-07-21
AU4995397A (en) 1998-05-22
AR008908A1 (en) 2000-02-23
PE11399A1 (en) 1999-02-09
KR20000052922A (en) 2000-08-25
CO4910128A1 (en) 2000-04-24
CA2268546A1 (en) 1998-05-07
WO1998018470A1 (en) 1998-05-07
HUP9904075A3 (en) 2002-02-28
CN1235545A (en) 1999-11-17
NZ335078A (en) 2000-10-27
AU731756B2 (en) 2001-04-05
ID23431A (en) 2000-04-20
NO992062D0 (en) 1999-04-29
HUP9904075A2 (en) 2000-05-28
ZA979731B (en) 1998-04-29

Similar Documents

Publication Publication Date Title
NZ294392A (en) Asthma drugs and compounds
IL129662A0 (en) Composition for the treatment of asthma containing loratadine and a decongestant
IL132424A0 (en) Prescription compliance device and method of using the device
EP0769974A4 (en) Improved inhaler and medicated package
HRP960365B1 (en) New medicaments and the use thereof
EP0803255A4 (en) Medicinal composition
HUT77918A (en) Device and use thereof for oxi-chlorination
IL125775A0 (en) Use of a zwitterion composition and a pharmaceutical composition containing the same
AU2621195A (en) Dental implant material and positioning device
IL116190A0 (en) Eleutherobin and analogs thereof
IL130348A0 (en) Imidazopyridazines and medicaments containing the same
GB9424499D0 (en) Game and associated apparatus
HUP9701618A3 (en) Pharmaceutical composition containing tramadol and a calcium-canal-antagonist
GB2294646B (en) Material treatment
GB9415901D0 (en) Novel compounds and treatment
IL102415A0 (en) Apparatus and techniques for manufacturing insoles
EP0799225A4 (en) Compounds and methods
GB9415900D0 (en) Novel compounds and treatment
HK1018941A (en) Composition, for the treatment of asthma, containing loratadine and a decongestant
ZA951226B (en) The treatment of gaseous substances
GB9617346D0 (en) Therapeutic methods and compositions for use therein
GB9413076D0 (en) Composition and use
HUP0003908A3 (en) Use of substituted azaspirane in the manufacture of a medicament for use in treating asthma
ZA959512B (en) Aryloxycycloalkenyl and aryloxyiminocycloalkenylhy-droxyureas
GB2294451B (en) Container and its manufacture